How long does Ativan (lorazepam) remain in the system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Long Ativan Lasts in Your System

Ativan (lorazepam) has a terminal elimination half-life averaging 14 hours (range 8-24 hours), meaning it takes approximately 3-5 days (70-120 hours) for the drug to be essentially eliminated from your system. 1

Pharmacokinetic Timeline

Immediate Effects

  • Clinical effects duration: 6-8 hours after a standard dose (2-4 mg) 1
  • Peak concentration:
    • Oral: 2-3 hours after administration 2, 3
    • Intramuscular: 1-3 hours 1
    • Intravenous: Immediate

Elimination Parameters

The FDA label provides definitive pharmacokinetic data 1:

  • Terminal half-life: 14 ± 5 hours in healthy adults
  • Total clearance: 1.1 ± 0.4 mL/min/kg
  • Volume of distribution: 1.3 L/kg
  • Protein binding: 91% bound to plasma proteins

Complete System Clearance

Using the standard pharmacokinetic principle that a drug is essentially eliminated after 5 half-lives:

  • 5 half-lives = 70 hours (approximately 3 days) for most adults
  • After this period, >97% of the drug is cleared from the body

Metabolism and Excretion

Lorazepam undergoes hepatic glucuronidation to an inactive metabolite 1:

  • 88% recovered in urine (74% as glucuronide conjugate)
  • 7% recovered in feces
  • Only 0.3% excreted unchanged in urine
  • The inactive glucuronide metabolite is eliminated primarily by the kidneys

Special Populations Requiring Extended Clearance Times

Elderly Patients

  • 20% reduction in clearance in patients 60-84 years old 1
  • Expect elimination to take 4-5 days rather than 3 days

Neonates

  • 80% reduction in clearance compared to adults
  • Terminal half-life prolonged 3-fold (approximately 42 hours) 1
  • Complete elimination may take 8-10 days

Renal Impairment

  • Terminal half-life increased by 25% in renal insufficiency 1
  • 75% increase in half-life for hemodialysis patients
  • Expect 4-6 days for complete elimination
  • Note: Only 8% removed during a 6-hour dialysis session 1

Hepatic Disease

No significant effect on lorazepam clearance - unlike other benzodiazepines, lorazepam does not undergo cytochrome P450 metabolism 1. Cirrhotic patients show no substantive difference in clearance compared to healthy subjects.

Clinical Implications for Residual Effects

Cognitive and Psychomotor Impairment

Even after clinical sedation wears off (6-8 hours), residual effects persist 1:

  • Visual tracking impairment: Mean of 8 hours after 4 mg IM dose
  • Enhanced CNS depression sensitivity: Documented in rare cases for >24 hours
  • Memory effects: Sufficient drug remains after 24 hours to suggest residual CNS effects 3

Drug Testing Detection Windows

Based on the elimination half-life and metabolite excretion:

  • Urine: Detectable for approximately 5-7 days after last dose
  • Blood/Serum: Detectable for approximately 3-4 days after last dose

Important Caveats

Prolonged administration causes tissue saturation 4:

  • With continuous or repeated dosing, lorazepam accumulates in peripheral tissues
  • Delayed emergence from sedation can occur due to this saturation
  • After prolonged use (>1-2 weeks), complete elimination may take significantly longer than 3 days

Propylene glycol accumulation with IV formulations 4:

  • The IV formulation contains propylene glycol as a diluent
  • Can accumulate with doses as low as 1 mg/kg/day
  • Monitor osmol gap (>10-12 mOsm/L suggests accumulation)
  • This adds an additional safety concern beyond lorazepam itself

Age-related clearance reduction 4:

  • Benzodiazepine clearance decreases with age
  • Elderly patients show significantly more sensitivity to sedative effects
  • Factor in longer elimination times for patients >60 years old

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.